1 treatment center
No centers match
Try a different search term
1 SAMHSA-listed treatment center in Chattanooga, Tennessee. Free, confidential help available 24/7 — most callers reach a licensed counselor in under 60 seconds.
Try a different search term
Free, confidential assistance matching you with the right program in Chattanooga.
Chattanooga, Tennessee has 1 SAMHSA-verified addiction treatment center offering 1 dual diagnosis, 1 outpatient. Each facility listed here is verified through the Substance Abuse and Mental Health Services Administration (SAMHSA) and provides evidence-based treatment approaches.
Outpatient programs allow Chattanooga residents to receive treatment while maintaining their daily responsibilities. Sessions are typically scheduled 3-5 days per week, making it possible to continue working or attending school.
Treatment centers in Chattanooga accept most major insurance plans including Medicaid, Medicare, Blue Cross Blue Shield, Aetna, Cigna, and UnitedHealthcare. Many facilities also offer sliding scale fees and payment plans. Call (319) 271-2077 to verify your coverage before admission.
Insurance coverage for addiction treatment in Chattanooga is governed by the Mental Health Parity and Addiction Equity Act (MHPAEA), which requires plans that cover substance-use treatment to do so at parity with medical/surgical benefits. In practice: if your plan covers a hospitalization for a heart condition, it must cover residential addiction treatment under comparable cost-sharing, day limits, and authorization requirements. The ACA further classifies substance-use disorder treatment as an Essential Health Benefit, meaning individual and small-group marketplace plans must include this coverage.
Mutual-support communities serving Chattanooga-area residents include Alcoholics Anonymous, Narcotics Anonymous, SMART Recovery (cognitive-behavioral-based, secular), Refuge Recovery (Buddhist-influenced), LifeRing (peer-led, no spiritual framework), and Recovery Dharma. Research evidence consistently shows that sustained engagement with any mutual-support community is associated with improved long-term outcomes — the specific framework matters less than the engagement itself and the fit between framework and patient preference.
The addiction-treatment landscape in Chattanooga, Tennessee, reflects the broader epidemiology of substance use in the region: alcohol use disorder remains the most prevalent diagnosis at treatment intake nationally, opioid use disorder presents the highest overdose mortality, stimulant use disorder is increasingly common (cocaine and methamphetamine), and polysubstance use is the rule rather than the exception. Chattanooga providers structure programs to address this diversity — most treat the full range of substance-use disorders within an integrated clinical framework rather than maintaining substance-specific tracks.
Depression co-occurs with substance use disorders at high rates and is often a treatment-complicating factor for Chattanooga patients. Substance use can mask depressive symptoms, withdrawal can produce transient depression, and protracted post-acute withdrawal syndrome (PAWS) can extend depressive episodes well past acute detox. Quality Chattanooga programs distinguish primary depression (preceded substance use) from substance-induced depression (would resolve with sustained abstinence) and treat accordingly — psychiatric medication management for the former, watchful waiting plus behavioral activation for the latter.
Outpatient counseling in Chattanooga addresses the lower-intensity end of the continuum — patients in early recovery who've completed higher-intensity programs and need ongoing support, patients with mild substance-use disorders who don't require intensive care, and patients in long-term recovery accessing maintenance therapy. Sessions are typically weekly or bi-weekly, individual and/or group, with content shaped by patient need: relapse-prevention skills, processing of underlying issues, family-system work, or co-occurring mental-health treatment.
Documentation and consent at Chattanooga program admission is structured to comply with 42 CFR Part 2 confidentiality of substance-use treatment records — a heightened standard above HIPAA. Patients typically sign multiple consent forms: treatment consent, releases for specific communications (with family, employer, legal contacts, other providers), and acknowledgments of program policies. These consents are revocable and patients retain control over disclosure of their treatment information except for narrow regulatory exceptions.
Withdrawal from alcohol or benzodiazepines can be medically dangerous and should not be attempted at home by Chattanooga residents with daily or heavy use. Signs of severe withdrawal requiring emergency care include seizures, hallucinations, severe tremor, disorientation, fever, and autonomic instability. Delirium tremens (DTs) carries 5% mortality without treatment and occurs in 3-5% of heavy alcohol users withdrawing. Medical detox at a licensed Chattanooga facility is the standard of care for these presentations.